Loading...
Experimental colitis in IL‐10‐deficient mice ameliorates in the absence of PTPN22
Interleukin (IL)‐10 plays a key role in controlling intestinal inflammation. IL‐10‐deficient mice and patients with mutations in IL‐10 or its receptor, IL‐10R, show increased susceptibility to inflammatory bowel diseases (IBD). Protein tyrosine phosphatase, non‐receptor type 22 (PTPN22) controls imm...
Na minha lista:
| Udgivet i: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693971/ https://ncbi.nlm.nih.gov/pubmed/31194881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13339 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|